Development of a patient‐centred conceptual framework of health‐related quality of life in neuromyelitis optica: a qualitative study

por Methley, Abigail M., Mutch, Kerry, Moore, Perry, Jacob, Anu
Publicado 2015

Health utilities and costs for neuromyelitis optica spectrum disorder

por Hughes, Dyfrig A., Bourke, Siobhan, Jones, Angela, Bhatt, Rikesh, Huda, Saif, Mutch, Kerry, Jacob, Anu
Publicado 2022

What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients

por Hamid, Shahd H. M., Whittam, Daniel, Mutch, Kerry, Linaker, Samantha, Solomon, Tom, Das, Kumar, Bhojak, Maneesh, Jacob, Anu
Publicado 2017

Predictors of relapse in MOG antibody associated disease: a cohort study

por Huda, Saif, Whittam, Daniel, Jackson, Richard, Karthikeayan, Venkatraman, Kelly, Patricia, Linaker, Sam, Mutch, Kerry, Kneen, Rachel, Woodhall, Mark, Murray, Katy, Hunt, David, Waters, Patrick, Jacob, Anu
Publicado 2021

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study

por Bove, Riley, Elsone, Liene, Alvarez, Enrique, Borisow, Nadja, Cortez, Melissa M., Mateen, Farrah J., Mealy, Maureen A., Mutch, Kerry, Tobyne, Sean, Ruprecht, Klemens, Buckle, Guy, Levy, Michael, Wingerchuk, Dean M., Paul, Friedemann, Cross, Anne H., Weinshenker, Brian, Jacob, Anu, Klawiter, Eric C., Chitnis, Tanuja
Publicado 2017